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Background: Rheumatoid arthritis (RA) is an autoim-
mune disease with progressive activity. The RA remis-
sion was observed in women during pregnancy, but
the  mechanism  responsible  for  remission  is  hypo-
thetical only and concerns mechanisms of immune
regulation  such  as  lymphocyte  subpopulations  and
interleukin production.
Aims: The  lymphocyte  subpopulations  and  inter-
leukin production in vitro in a group of healthy non-
pregnant women, healthy pregnant women and preg-
nant women suffering from RA may help towards a
better  understanding  of  regulation  of  the  immune
processes.
Methods: The investigations were performed  in tri-
mester III – 2 days after delivery and 6 weeks after
delivery. Peripheral blood lymphocytes were isolated
on  Gradisol  gradient  and  analysed  immediately  or
after  having  been  cultured  for  72  hours  in  RPMI
medium  supplemented  with  10%  FCS.  The  cultures
were  terminated  after  72 h,  supernatants  stored  at
–72°C for interleukin evaluation. The concentrations
of  IFN-g ,  IL-2,  IL-6,  IL-12,  TNF-a and  its  soluble
receptors R-I, R-II were estimated in non-stimulated
and  PHA (Sigma, 5 m g/ml) stimulated culture super-
natants  using  ELISA  Endogen  kits  according  to  the
manufacturer’s instructions.
Results: The general pattern of T cell subpopulation
distribution  was  similar  in  all  analysed  groups.
Decreased IFN-g , IL-12 and increased IL-6 production
by lymphocytes after PHA stimulation was found in
trimester III in pregnant women with RA as compared
to healthy pregnant woman.
Conclusion: The  obtained  results  suggest  that  in
pregnant  women  with  RA  the  TH1  cell  response
predominates, contrary to healthy pregnant women
with TH2  type functional response. These phenom-
ena were not observed after delivery.
Key words: Human pregnancy and RA, IFN-g, IL-12 and
IL-6 production
Introduction
Rheumatoid arthritis (RA) is an autoimmune disorder
associated with  HLA  class  II  genes  responsible  for
disease progression.1Autoreactive CD4+CD28-T cells
undergo clonal expansion in vivo and thus contribute
to the pathogenesis of RA.2These cells produce high
levels of IFN-g and preferentially express killer  cell
activating  receptors  in  the  absence  of  inhibitory
receptors.3 Pregnancy influences the disease severity
in woman with rheumatoid arthritis, but no specific
factor responsible for improvement has been identi-
fied.4 The general view exists that in pregnancy the
immune  relationship  between  mother  and  fetus  is
suppressed.  Suppression  in  pregnancy  depends  on
hormonal factors such as progesterone depressing the
immune  response and  autoimmune  diseases, but  is
effectively compensated by the innate system avoid-
ing infection. The innate immune system components
including phagocytes complement system and acute
phase proteins are stimulated in pregnancy and may
affect the disease. The RA clinical picture is charac-
terised  by  widespread  variability  in  a  pregnant
woman:  remission,  improvement  in  parameters  of
disease  activity,  nevertheless  only  16  per  cent  of
pregnant women with RA are in complete remission.5
Pregnancy also ameliorates the experimental autoim-
mune  uveitis  in  mice  probably  as  the  effect  of
selective reduction of Th1 response.6The interaction
between  the  maternal  immune  system  in  human
pregnancy and some autoimmune diseases depends
on the type of dominant immune reaction: remission
of RA in pregnant women is connected with exacer-
bation  after  delivery  but  exacerbation  of  systemic
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in pregnant woman.7We suggest that RA remission in
pregnancy is the effect of diminished IFN-g production
and misbalance in IL-6 and IL-12 production, effects
which are almost reversed in the postpartum period.
Materials and methods
Patients
We have investigated the following groups of patients:
14 healthy nulliparous women, volunteers from the
hospital  staff,  14  healthy  pregnant  women,  and  6
pregnant women suffering from rheumatoid arthritis
(Table 1). All patients were 20–30 years old (mean
24.7). Pregnant women were observed from trimester
I of pregnancy to 6 weeks after delivery (at that time
a few refused). At the time of study and for at least 4
weeks before no patient had clinical signs of active
infection. All  patients with RA fulfilling  the revised
American Rheumatology Association (ARA)  criteria8
were included in this study.
Methods
The venous blood samples were collected between
8–9 am to Vacutainer probes on Heparin 10 U/ml, all
tests  were  performed  within  2h  after  withdrawal.
Peripheral blood lymphocytes were isolated on Gradi-
sol  gradient9 and  analysed  immediately  after  with-
drawal or after 72h culture (2´ 106 cells/ml) in RPMI
medium  supplemented  with 10%  foetal calf  serum,
glutamine,  and  antibiotics.  PHA  (Sigma)  5mg/ml
lymphocytes (1´ 106/ml) were cultured in CO2incuba-
tor on 0.2 Nunc plates in RPMI medium supplemented
with 10% of fetal calf serum (Hungarpol). The cultures
were  terminated  after  72h,  supernatants  stored  at
–72°C  for  interleukin  evaluation.  Measurements  of
IFN-g, IL-2, IL-6, IL-12, TNF-a and it soluble receptors
R-I, R-II were performed in non-stimulated and PHA
stimulated culture supernatants using ELISA Endogen
kits according to the manufacturer’s instructions.
The lymphocytes submitted to subpopulation ana-
lyses were washed and incubated with 10% solution
of mouse serum at room temperature. They were then
incubated with FITC conjugated anti CD3, CD4, CD8,
and CD19 mo Ab respectively, then washed and fixed
with 1% paraformaldehyde solution. CD4 RO, RA and
CD8 RO, RA antigen expression was evaluated by a
double  staining  procedure  and  labeled  cells  were
fixed in 1% paraformaldehyde and analyzed using a
Becton–Dickinson  cytometer.  The  results  are
expressed as the percentage of gated double positive
cells for antibodies used versus all lymphocytes.
Statistical assessments
The  arithmetic  means  (X)  and  standard  deviations
(SD)  were  calculated  for  all  parameters.  Statistical
analyses of differences in all of the data were done
using the Student-t test using the software program
Statistica. Statistical significance was set at P £  0.05.
The  Institute  Ethics  Committee  approved  the
experimental  protocol.  All  reported  investigations
have been performed in accordance with the Declara-
tion of Human Rights (Helsinki 1964). Blood samples
were generally taken in the course of routine exam-
inations.  Informed  consent  was  obtained  from  all
investigated patients.
Results
The general pattern of T cell subpopulation distribu-
tion was similar in all analysed groups, differences in
individual  results  were  usually  high  therefore  the
statistical significance could not be calculated for most
of the analysed results. The significant differences are
outlined as follows: CD19 (B lymphocytes) decreased
in  pregnant  women  but  significantly  increased  in
pregnant  women  with  RA.  These  differences  dis-
appeared 6 weeks after delivery. The percentage of NK
cells in healthy pregnant women decreased from 17.4
in trimester III, 18.5 two days after delivery to 7.0 6
weeks after delivery; in pregnant women with RA the
respective data are 9.4, 10.4 and 11.5. In vitro culture
did not reveal any differences in the pattern of CD
antigen distribution.
The  ability  to  produce  IL-12,  IL-6  and  IFN-g by
peripheral  blood  mononuclear  cells  (PBMC)  stimu-
lated with  PHA  in  vitro revealed dynamic  changes
dependent on pregnancy and the clinical status of the
investigated  women  (Fig.  1A,B,C).  IL-12  (Fig.  1A)
production by stimulated PBMC of pregnant women
with RA was diminished in trimester III of pregnancy,
significantly  increased  2  days  after  delivery  and
normalised  6  weeks  after  delivery.  IL-6  (Fig.  1B)
production  by  stimulated  PBMC  was  generally
enhanced in pregnant women suffering from RA. IFN-g
(Fig. 1C) production by stimulated PBMC of healthy
pregnant woman was enhanced in trimester III and
normalised after delivery contrary to PBMC of preg-
nant woman suffering from RA. Surprisingly, the  TNF-a
H. Tch´ orzewski et al.
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Table 1. Characteristics of the women investigated
Group n Age
(years)
Clinical and laboratory tests
Healthy 14 20–30 No signs of disease.
Blood and urine normal
Pregnant 14 19–31 No signs of disease.
Blood and urine normal
Pregnant
with RA
6 20–30 RF positive in 4 patients,
blood and urine normal,
sedimentation rate increased,
no joint and muscle painF
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(R-I  and  R-II)  shedding  generally  did  not  reveal
significant differences between analysed groups (not
shown). The obtained data have suggested a specific
regulatory effect in pregnant women with RA on the
ability of PBMC to produce some cytokines that affect
clinical outcome.
Discussion
Human  pregnancy  is  compared  with  tissue  trans-
plantation but clearly is not the same. Fetal allograft
does not require surgical trauma, it takes place in a
unique  specialized  organ  i.e.  uterus,  grows  pro-
gressively  as  the  placenta  produces  hormones  and
cytokines  responsible  for  suppression  of  specific
immune  reactions,  occurring  during  establishment
and maintenance of pregnancy.5,10 Successful implan-
tation of pregnancy is thought to require the estab-
lishment  of  Th2  cytokines  profile  of  CD4  cells.
Progesterone and interleukins 4 and 10 suppress Th1
cytokine  responses  and  this  is  predicted  to  be
responsible  for  remission  of  rheumatoid  arthritis
during pregnancy.10The central role in the adaptation
of suppressed maternal immune system in pregnancy
to avoid infection is activation of the innate immune
reaction  such  a  complement  system,  phagocytosis,
oxygen  burst,  IL-12  and  chemokines  production
which is  in  some  way  comparable to sepsis.11 The
increased IFN-g production in human uterine endo-
metrium also plays an important role in modulating
immune  responses  to  infectious  challenge.  IFN-g
makes the lymphocytes and neutrophils functionally
hyperactive and can exert an autocrine stimulatory
effect.11We have observed the significantly enhanced
IFN-g production by  PBL  of  pregnant woman  after
PHA  stimulation  in  vitro.  PBL  of  pregnant  women
with RA in the same conditions do not produce an
enhanced amount  of  IFN-g.  Dendritic cells  derived
from non-obese diabetic mice treated in vitro with
IFN-g could protect from diabetes when transferred
into  susceptible  mice.12 Hypothetically,  the  same
mechanisms  responsible  for  INF-g production  in
normal human pregnancy can effectively protect from
autoimmune diseases. Diminished IFN-g production
in pregnant women with RA may be responsible for
disease exacerbation.
IL-6 is required for the development of autoimmune
arthritis;  IL-6  deficient  mice  are  resistant  to  the
induction of autoimmune disease.13 It has been found
that IL-6 is required for disease development in the
rodent autoimmune model. IL-6 pretreated dendritic
cells can process autoantigen, present cryptic deter-
minants to T cells and contribute to the autoimmun-
ity.13 Slightly  diminished  IL-6  production  by  non-
stimulated lymphocytes from pregnant woman with
RA and enhanced IL-6 production after PHA stimula-
tion has proved the possibility that IL-6 can play a key
role in the development of arthritis in these patients.
Reduced severity of RA was observed in IL-6 deficient
mice.14 The rational explanation of these differences
is difficult but could suggest the existence of specific
regulatory mechanisms involved in RA during preg-
nancy. Anti IL-12 and anti TNF-antibodies suppress the
progression of murine experimental arthritis.15 Block-
ing the functional IL-12 secretion by dendritic cells
inhibits IFN-g production.16The reduced amounts of
IL-12  production  in  vitro by  stimulated  PBL  of
pregnant women with RA may result in the genera-
tion  of  Th1  cells.  Exogenous  IL-12  modified  the
development of Th cells primed in vitro by dendritic
cells,  which  resulted  in  the  generation  of Th1-like
cells from naive precursor. However, in vivo dendritic
cells are effective inducers of both Th1- and Th2-type
cytokines.  Our  results  show  that  diminished  IL-12
generation by lymphocytes of pregnant women with
RA  in  trimester  III  correlated  with  enhanced  IL-6
production and lowered IFN-g secretion which may
result in a Th1 cell-biasing function contrary to the
observed  down-regulation  of  Th1  response  during
normal pregnancy.5 McRae et al.,16 using purified cell
lines  proved  that  IL-12  promotes  differentiation  of
CD4  T  cells  to  produce  IFN-g.  Diminished  IL-12
production  in  trimester  III  of  pregnancy  may  also
result in inhibition of IFN-g production but IL-12 over-
production  after  delivery  does  not  confirm  such  a
hypothesis and suggests that the mechanism responsi-
ble for RA exacerbation in the postpartum period is
more complicated. An immunomodulatory  effect  of
non-inherited HLA antigens cannot be excluded.5
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